hat
BioMarin soumèt aplikasyon Lisans Biyolojik nan US Administrasyon Manje ak Medikaman pou Valoctocogene Roxaparvovec Trete Emofil A
eng
BioMarin Submits Biologics License Application to U.S. Food and Drug Administration for Valoctocogene Roxaparvovec to Treat Hemophilia A